Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Trends Neurosci. 2020 Dec 21;44(4):260–275. doi: 10.1016/j.tins.2020.11.008

Table 1. The binding affinities of ketamine and psilocin for various receptor types.

Ki values, binding affinity (nM)
Ketamine Psilocin Radioligand
5-HT1A Low affinity 567 [3H]-8-OH-DPAT
5-HT1B Low affinity 220 [3H]-GR-125743
5-HT1D Low affinity 36 [3H]-GR-125743
5-HT1E Low affinity 52 [3H]-5HT
5-HT2A Low affinity 107 [3H]-Ketanserin
5-HT2B Low affinity 5 [3H]-LSD
5-HT2C Low affinity 97a [3H]-Mesulergine
5-HT3 Low affinity Low affinity [3H]-LY 278584
5-HT5 Low affinity 84 [3H]-LSD
5-HT6 Low affinity 57 [3H]-LSD
5-HT7 Low affinity 4 [3H]-LSD
5-HT transporter N.A. 3,801 [3H]-Citalopram
NMDA 661a N.A. [3H]-MK-801
Adrenergic α2A Low affinity 1,379 Ketamine: [3H]-Rauwolscine; Psilocin: [125I]-Clonidine
Adrenergic α2B Low affinity 1,894 Ketamine: [3H]-Rauwolscine; Psilocin: [125I]-Clonidine
Dopamine D3 Low affinity 2,645a Ketamine: [3H]-N-Methylspiperone; Psilocin: [3H]-NMSP
Histamine H1 Low affinity 305 [3H]-Pyrilamine

Low affinity, Ki >10,000 nM

N.A., not available

Source: NIMH Psychoactive Drug Screen Program (PDSP) [129]. Ki values are PDSP certified values (human data except where a indicates value from rats when human data were unavailable). Note that values for ketamine are for the racemic mixture, which consists of (S)- and (R)-ketamine that are converted into multiple metabolites. The enantiomers and metabolites have varying affinities to NMDAR and other receptors [22].